Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Restructuring Costs (2019 - 2025)

Historic Restructuring Costs for Healthequity (HQY) over the last 7 years, with Q4 2025 value amounting to $1.2 million.

  • Healthequity's Restructuring Costs fell 9663.44% to $1.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.9 million, marking a year-over-year decrease of 8553.46%. This contributed to the annual value of $40.5 million for FY2025, which is 28845.23% up from last year.
  • Healthequity's Restructuring Costs amounted to $1.2 million in Q4 2025, which was down 9663.44% from $1.3 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Restructuring Costs ranged from a high of $34.4 million in Q4 2024 and a low of $1.2 million during Q4 2025
  • Over the past 5 years, Healthequity's median Restructuring Costs value was $4.3 million (recorded in 2023), while the average stood at $8.1 million.
  • Per our database at Business Quant, Healthequity's Restructuring Costs soared by 119706.21% in 2024 and then plummeted by 9663.44% in 2025.
  • Healthequity's Restructuring Costs (Quarter) stood at $13.2 million in 2021, then crashed by 50.85% to $6.5 million in 2022, then crashed by 59.21% to $2.7 million in 2023, then skyrocketed by 1197.06% to $34.4 million in 2024, then crashed by 96.63% to $1.2 million in 2025.
  • Its Restructuring Costs stands at $1.2 million for Q4 2025, versus $1.3 million for Q3 2025 and $1.3 million for Q2 2025.